DO WE NEED TO EXTEND CMV PROPHYLAXIS COURSE IN HIGH RISK PATIENTS POST TRANSPLANT? A SINGLE CENTRE RETROSPECTIVE STUDY OF CMV INFECTION IN KIDNEY TRANSPLANT PATIENTS

被引：0
|
作者：
Aswad, Mayar Ghazal [1 ]
Smith, Christopher [1 ]
Khan, Shakeeb [1 ]
Page, Amy [1 ]
Black, John [1 ]
Chughtai, Shafiq [1 ]
Dharmayan, Stalin [1 ]
Ali, Ahmed [1 ]
Rajagopal, Poyyamozhi [1 ]
Doughman, Tahir [1 ]
Malik, Shafi [1 ]
Bagul, Atul [1 ]
机构：
[1] Univ Hosp Leicester, Leicester, Leics, England
来源：
TRANSPLANT INTERNATIONAL | 2017年 / 30卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
P379
引用
收藏
页码：491 / 491
页数：1
相关论文
共 50 条
  • [31] The Influence of Antithymocyte Globulin Dose on the Incidence of CMV Infection in High-risk Kidney Transplant Recipients Without Pharmacological Prophylaxis
    de Paula, Mayara, I
    Bae, Sunjae
    Shaffer, Ashton A.
    Garonzik-Wang, Jacqueline
    Felipe, Claudia R.
    Cristelli, Marina P.
    Waldram, Madeleine M.
    Massie, Allan B.
    Medina-Pestana, Jose
    Segev, Dorry L.
    Tedesco-Silva, Helio
    TRANSPLANTATION, 2020, 104 (10) : 2139 - 2147
  • [32] Anti-cmv prophylaxis after transplant significally reduces the risk of disease in thalassemic patients
    Baronciani, D
    Angelucci, E
    Lucarelli, G
    Gazlev, D
    Erer, B
    Giardini, C
    Polchi, P
    Shafii, M
    Sodani, P
    Visani, G
    BONE MARROW TRANSPLANTATION, 2002, 29 : S132 - S133
  • [33] POST-KIDNEY TRANSPLANT CMV INFECTION GRAFT AND PATIENT OUTCOME: 4 YEARS FOLLOW-UP, SINGLE CENTRE EXPERIENCE
    Elmghrbee, Abdulwhab
    Abounozha, Sabry
    Idrees, Adli
    Ridgway, Dan
    Hammad, Abdul
    TRANSPLANT INTERNATIONAL, 2019, 32 : 193 - 193
  • [34] CMV Infection in Renal Transplant Patients: Single Center Analysis of Direct and Indirect Effects
    Oliveira, J.
    Rivelli, G. G.
    Mazzali, M.
    TRANSPLANTATION, 2012, 94 (10) : 546 - 546
  • [35] PREDICTIVE RISK FACTORS OF POST-TRANSPLANT HIGH-GRADE CMV REACTIVATION IN CMV-SEROPOSITIVE PATIENTS IN THE MODERN IMMUNOSUPPRESSIVE ERA
    Saito, Mitsuru
    Satoh, Shigeru
    Tsuruta, Hiroshi
    Akihama, Susumu
    Inoue, Takamitsu
    Narita, Shintaro
    Tsuchiya, Norihiko
    Habuchi, Tomonori
    JOURNAL OF UROLOGY, 2015, 193 (04): : E1068 - E1068
  • [36] CMV Donor and Recipient (D/R) Serostatus: Impact of Prophylaxis on Outcomes in US Kidney Transplant Patients
    Irish, W.
    Loveless, M.
    Pietrangeli, C.
    Levy, D.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 : 468 - 468
  • [37] Prolonged use of letermovir as CMV reactivation prophylaxis significantly reduces the risk of CMV reactivation in persistently immunocompromised stem cell transplant patients
    Koch, K.
    Osswald, L.
    Miller, I.
    Braitsch, K.
    Goetze, K.
    Bassermann, F.
    Herhaus, P.
    Verbeek, M.
    ONCOLOGY RESEARCH AND TREATMENT, 2022, 45 (SUPPL 2) : 242 - 242
  • [38] Outcome of hepatitis C patients coinfected with cytomegalovirus (CMV) infection post liver transplant (LTx).
    Bozorgzadeh, A
    Abt, P
    Kashyap, R
    Lansing, K
    Younan, D
    Jain, A
    Mantry, P
    Orloff, M
    LIVER TRANSPLANTATION, 2005, 11 (07) : C48 - C48
  • [39] Effectiveness of decreasing the risk of transfusion transmitted CMV infection in heart and lung transplant patients using CMV safe blood components
    Lopez-Plaza, I
    Triuizi, DJ
    Kusne, S
    TRANSFUSION, 1999, 39 (10) : 84S - 85S
  • [40] Outcome of hepatitis C patients coinfected with cytomegalovirus (CMV) infection post liver transplant (LTx).
    Bozorgzadeh, A
    Abt, P
    Kashyap, R
    Lansing, K
    Younan, D
    Jain, A
    Mantry, P
    Orloff, M
    AMERICAN JOURNAL OF TRANSPLANTATION, 2005, 5 : 178 - 178
12345